<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Since 1970, we have carried out <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> chemotherapy and immunotherapy in cooperation with Japanese scientists, particularly Prof </plain></SENT>
<SENT sid="1" pm="."><plain>H </plain></SENT>
<SENT sid="2" pm="."><plain>Umezawa, who has generously supplied <z:chebi fb="0" ids="3139">bleomycin</z:chebi>, peplomycin, acalcinomycin A (ACM), <z:chebi fb="0" ids="46941">THP</z:chebi>-adriamycin (<z:chebi fb="0" ids="46941">THP</z:chebi>), neothramycin and bestatin </plain></SENT>
<SENT sid="3" pm="."><plain><z:mp ids='MP_0002018'>Malignant tumors</z:mp> curable by pharmacotherapy are <z:hpo ids='HP_0001901'>polycythemia</z:hpo> vera (CR 100%), <z:hpo ids='HP_0006721'>acute lymphoid leukemia</z:hpo> (ALL) (CR 80%), <z:e sem="disease" ids="C0006413" disease_type="Neoplastic Process" abbrv="BL">Burkitt tumor</z:e> (CR 80 or 50%), <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin disease</z:e> (CR 80%), <z:e sem="disease" ids="C0008497" disease_type="Neoplastic Process" abbrv="">chorioepithelioma</z:e> (CR 80%), <z:e sem="disease" ids="C0153594" disease_type="Neoplastic Process" abbrv="">testicular cancer</z:e> (CR 80%), <z:e sem="disease" ids="C1140680" disease_type="Neoplastic Process" abbrv="">ovary cancer</z:e> of children (CR 80%), Wilms <z:e sem="disease" ids="C0740457" disease_type="Neoplastic Process" abbrv="">renal cancer</z:e> (CR 60%), <z:hpo ids='HP_0002859'>rhabdomyosarcoma</z:hpo> (CR 75%), <z:hpo ids='HP_0002669'>osteosarcoma</z:hpo> (CR 60%), <z:e sem="disease" ids="C0553580" disease_type="Neoplastic Process" abbrv="">Ewing tumor</z:e> (CR 60%), <z:mp ids='MP_0009277'>brain tumor</z:mp> of children (CR greater than 50%), testicular <z:e sem="disease" ids="C0751364" disease_type="Neoplastic Process" abbrv="">embryonal cancer</z:e> of children (CR greater than 50%), <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) (CR 50%), non-Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (NHL) (CR 50%), <z:e sem="disease" ids="C1140680" disease_type="Neoplastic Process" abbrv="">ovary cancer</z:e> of adults (CR 40%), <z:e sem="disease" ids="C0149925" disease_type="Neoplastic Process" abbrv="SCLC">small cell lung cancer</z:e> (CR 20%) and <z:hpo ids='HP_0003002'>breast cancer</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Our experimental and/or clinical experience with ACM, <z:chebi fb="0" ids="46941">THP</z:chebi>, <z:chebi fb="8" ids="32772">methoxy</z:chebi>-9-ellipticine <z:chebi fb="4" ids="24996">lactate</z:chebi>, navelbine, 4-demethyl-epipodophyllotoxin-beta-d-ethyledene <z:chebi fb="3" ids="15903">glucoside</z:chebi>, bestatin and interferon is presented </plain></SENT>
<SENT sid="5" pm="."><plain>ACM is effective against <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>, ALL, NHL, <z:e sem="disease" ids="C0006413" disease_type="Neoplastic Process" abbrv="BL">Burkitt tumor</z:e>, <z:hpo ids='HP_0003002'>breast cancer</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>We have comparatively investigated cardiac and dermal toxicity of 12 kinds of <z:chebi fb="0" ids="49322">anthracycline antibiotics</z:chebi> and <z:chebi fb="0" ids="50729">mitoxantrone</z:chebi>, using golden hamsters </plain></SENT>
<SENT sid="7" pm="."><plain>Of the drugs examined, ACM, <z:chebi fb="0" ids="46941">THP</z:chebi>, AD-32 and AD-143 cause much less <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> and <z:hpo ids='HP_0001596'>alopecia</z:hpo> than the other agents </plain></SENT>
<SENT sid="8" pm="."><plain>The results have been confirmed by electron microscopic studies </plain></SENT>
<SENT sid="9" pm="."><plain>Bestatin is an immunorestorator, which recovers immunological functions decreased in aged animals </plain></SENT>
<SENT sid="10" pm="."><plain>We hope that <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> chemotherapy and immunotherapy will progress in future and contribute to cure of <z:hpo ids='HP_0002664'>neoplasms</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>Japanese scientists have been making a great contribution in the field of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> pharmacotherapy, and we are eager to cooperate with Japanese scientists in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> treatment studies </plain></SENT>
</text></document>